Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation

Hepatology

Volumn 30, Issue 3, 1999, Pages 775-778

  Hézode, Christophe ^a   Duvoux, Christophe ^a   Germanidis, Georgios ^a   Roudot Thoraval, Françoise ^a   Vincens, Anne Laure ^a   Gaulard, Philippe ^a   Cherqui, Daniel ^a   Pawlotsky, Jean Michel ^a   Dhumeaux, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; B-LYMPHOCYTES; FEMALE; HEPATITIS C; HERPESVIRUS 4, HUMAN; HUMANS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED;

EID: 0032841857     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300314     Document Type: Article

References (20)

1. Basgoz N, Preiksaitis JK. Post transplant lymphoproliferative disorder. Infect Dis Clin North Am 1995;9:901-923.
2. Hanto DW. Classification of Epstein-Barr virus associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995;46:381-394.
3. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 1996;2:52-59.
4. Oudejans J, Jiwa NM, Van den Brule AJC, Meijer CJLM. Epstein-Barr virus and its possible role in the pathogenesis of B-cell lymphomas. Crit Rev Oncol Hematol 1997;25:127-138.
5. Silvestri F, Baccarani M. Hepatitis C virus-related lymphomas. Br J Haematol 1997;99:475-480.
6. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:4296-4301.
7. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:423-428.
8. Agnello V. Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective. HEPATOLOGY 1997;26:1375-1379.
9. Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 1997;4:9-28.
10. Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dhumeaux D, Reyes F. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999;93:1778-1779.
11. Cherqui D, Duvoux C, Salvat A, Lauzet JY, Metreau JM, Julien M, Fagniez PL, et al. High dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function. A prospaective study. Transplant Proc 1995;27:1134-1135.
12. Cordell JL, Falini B, Erber W, Ghosh AK, Abdullaziz Z, MacDonald S, Pulford K, et al. Immunoenzymatic labeling of antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase. J Histochem Cytochem 1984;32:219-229.
13. Sabourin JC, Kanavaros P, Briere J, Lescs MC, Petrella T, Zafrani ES, Gaulard P. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in nonimmunocompromised patients. Am J Surg Pathol 1993;17:995-1002.
14. Giannelli F, Mazzocca A, Ferri C, Marrocchi ME, Monti M, Giannini C, Gentilini P, et al. Relevance of T(14;18) translocation in pathogenesis of HCV-related lymphoproliferative disorders [Abstract]. HEPATOLOGY 1998; 28:463A.
15. Monteverde A, Sabattini E, Poggi S, Ballare M, Bertoncelli MC, De Vivo A, Briskomatis A, et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Lek Lymphoma 1995;20:119-124.
16. Ray RB, Meyer K, Steele R, Shrivastava A, Aggarval BB, Ray R. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem 1998;273:2256-2259.
17. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.
18. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 1998;338: 1413-1421.
19. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international study group. Blood 1994;84: 1361-1392.
20. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552-565.